Roche defends buying lavish meals for doctors at Sydney's restaurantsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7560.169 (Published 20 July 2006) Cite this as: BMJ 2006;333:169
- Ray Moynihan
- Byron Bay, Australia
The Swiss drug giant Roche has been accused of breaching the pharmaceutical industry's code of conduct by providing lavish meals to doctors at several of Australia's leading restaurants.
The dinners were part of a Roche sponsored scientific symposium on haematology-oncology treatments, which included the company's top selling pharmaceutical, rituximab (MabThera), which has annual sales of more than SFr4bn (£1.8bn; €2.6bn; $3.2bn).
According to documents obtained by the BMJ, Roche spent more than $A65000 (£27 000; €39 000; $49 000) on one meal for almost 300 people at the Guillaume at Bennelong restaurant, in the Sydney Opera House in July 2005.
With spectacular views over Sydney harbour, the restaurant is considered one of Australia's best, boasting the “degustation …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial